Pay in 4 interest-free payments of $47.50 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Hepatic and pancreatic metabolism and biliary excretion of the protease inhibitor camostat mesilate
9-trimethyl-
in spontaneously hypertensive rats
2ClH/c1-45(21-29-32(54-3)18-24(19-33(29)55-4)28-22-46(2)38(51)27-20-41-11-10-25(27)28)23-35(49)43-13-15-57-17-16-56-14-12-42-30-7-5-6-26-36(30)40(53)47(39(26)52)31-8-9-34(48)44-37(31)50
CAS Number: 7013-05-0
Cilomilast Size:10mg solid Hepatic and pancreatic metabolism andCilomilast (Ariflo, SB 207, 499) is a drug which was developed for the treatment of respiratory disorders such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It is orally active and acts as a selective Phosphodiesterase 4 inhibitor. Clinical trial results showed reasonable efficacy for treating COPD, but side effects were problematic and it is unclear whether cilomalast will be marketed, or merely used in the development of newer drugs.
US$ 77.16
US$ 624.50
US$ 2599.50
US$ 799.50